How The Arvinas (ARVN) Story Is Evolving As 2026 Neurology Catalysts Approach [Yahoo! Finance]
Arvinas, Inc. (ARVN)
Last arvinas, inc. earnings: 11/4 05:00 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
The Arvinas fair value estimate has shifted from US$14.56 to US$14.88 per share, a small move that still matters if you are tracking valuation updates closely. Street research ties this change to refreshed views after the Q4 update, including new milestones in the neurology pipeline and a split between more optimistic and more cautious price targets that now cluster roughly between US$11 and US$20. As you read on, you will see how to interpret these revisions and keep up with the evolving Arvinas story over time. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Arvinas. What Wall Street Has Been Saying ?? Bullish Takeaways Citi and Evercore ISI have both moved targets higher into the mid to high teens, with Citi lifting its view to US$18 and Evercore ISI to US$19, reflecting updated models after the Q4 report. Evercore ISI points to Arvinas "gearing up for a pivotal 2026," highlighting anticipated data read
Show less
Read more
Impact Snapshot
Event Time:
ARVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARVN alerts
High impacting Arvinas, Inc. news events
Weekly update
A roundup of the hottest topics
ARVN
News
- Arvinas (ARVN) had its price target raised by Citigroup Inc. from $18.00 to $21.00. They now have a "buy" rating on the stock.MarketBeat
- Arvinas (ARVN) had its price target raised by BTIG Research from $14.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
- Arvinas (ARVN) was given a new $10.00 price target by Truist Financial Corporation.MarketBeat
- Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson's Disease Treated for 28 Days [Yahoo! Finance]Yahoo! Finance
- Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson’s Disease Treated for 28 DaysGlobeNewswire
ARVN
Earnings
- 2/24/26 - Miss
ARVN
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/19/26 - Form 4
- 3/18/26 - Form 8-K
- ARVN's page on the SEC website